Similarity, yet paradoxically, miR-133b was significantly lower in primary resistant ovarian carcinomas and cell lines and reduced ovarian cancer drug resistance by silencing the expression of the drug-resistance-related proteins, glutathione S-transferase(GST-π) and multidrug resistance protein 1 (MDR1) [73]. The gene discussed is GSTP1; the disease is ovarian carcinoma.